GlassScriptPhysician profile
Brian K Keller
NPI 1215994959
$4,108.07
in general payments reported to CMS, 2019-2025
45 companies · $820 in 2025
The $820 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $324 · 2021: $515 · 2022: $926 · 2023: $563 · 2024: $683 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $583.68 | 2019-2025 | |
| Novo Nordisk INC | $437.01 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $434.83 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Astrazeneca Pharmaceuticals LP | $341.11 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $303.99 | 2019-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $295.34 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Astellas Pharma US INC | $204.16 | 2019-2024 | Veozah, Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $142.85 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $128.45 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $104.99 | 2023-2025 | Gemtesa |
| Dentsply Sirona INC | $100.00 | 2020 | |
| Lilly USA, LLC | $99.94 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Boston Scientific Corporation | $79.35 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Sunovion Pharmaceuticals INC. | $62.90 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.69 | 2022-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.